Format
Sort by
Items per page

Send to

Choose Destination

Best matches for mammary ductal carcinoma AND BCL2:

Search results

Items: 1 to 20 of 57

1.

Immunophenotyping of male breast cancer - Experience at a tertiary care centre.

Pasricha S, Kamboj M, Tanwar P, Gupta G, Panigrahi M, Sharma A, Durga G, Mehta A.

Indian J Pathol Microbiol. 2019 Apr-Jun;62(2):226-231. doi: 10.4103/IJPM.IJPM_543_18.

PMID:
30971545
2.

[Intravascular lymphoma simulating relapse of breast cancer: An original clinical case].

Herrscher H, Blind A, Freysz M, Cribier B, Mahé A.

Ann Dermatol Venereol. 2019 Apr;146(4):292-296. doi: 10.1016/j.annder.2019.01.012. Epub 2019 Mar 21. French.

PMID:
30904278
3.

Trefoil factors peptide-3 is associated with residual invasive breast carcinoma following neoadjuvant chemotherapy.

Al-Salam S, Sudhadevi M, Awwad A, Al Bashir M.

BMC Cancer. 2019 Feb 11;19(1):135. doi: 10.1186/s12885-019-5316-y.

4.

Prognostic Value of BCL2 in Women Patients with Invasive Breast Cancer

Ayadi EZ, Cherif B, Ben Hamed Y, Mokni M, Rebai A, Ayadi H, Jlidi R.

Asian Pac J Cancer Prev. 2018 Dec 25;19(12):3557-3564.

5.

DNA repair and apoptosis: Roles in radiotherapy-related acute reactions in breast cancer patients.

Batar B, Mutlu T, Bostanci M, Akin M, Tuncdemir M, Bese N, Guven M.

Cell Mol Biol (Noisy-le-grand). 2018 Mar 31;64(4):64-70.

PMID:
29631685
6.

Influence of intra-tumoral heterogeneity on the evaluation of BCL2, E-cadherin, EGFR, EMMPRIN, and Ki-67 expression in tissue microarrays from breast cancer.

Tramm T, Kyndi M, Sørensen FB, Overgaard J, Alsner J.

Acta Oncol. 2018 Jan;57(1):102-106. doi: 10.1080/0284186X.2017.1404128. Epub 2017 Dec 4.

PMID:
29202620
7.

Niche-localized tumor cells are protected from HER2-targeted therapy via upregulation of an anti-apoptotic program in vivo.

Zoeller JJ, Bronson RT, Selfors LM, Mills GB, Brugge JS.

NPJ Breast Cancer. 2017 May 1;3:18. doi: 10.1038/s41523-017-0020-z. eCollection 2017. Erratum in: NPJ Breast Cancer. 2017 Sep 22;3:38.

8.

DNA methylation contributes to deregulation of 12 cancer-associated microRNAs and breast cancer progression.

Pronina IV, Loginov VI, Burdennyy AM, Fridman MV, Senchenko VN, Kazubskaya TP, Kushlinskii NE, Dmitriev AA, Braga EA.

Gene. 2017 Mar 10;604:1-8. doi: 10.1016/j.gene.2016.12.018. Epub 2016 Dec 18.

PMID:
27998789
9.

Different Biological Action of Oleic Acid in ALDHhigh and ALDHlow Subpopulations Separated from Ductal Carcinoma In Situ of Breast Cancer.

Kim HS, Jung M, Choi SK, Moon WK, Kim SJ.

PLoS One. 2016 Sep 2;11(9):e0160835. doi: 10.1371/journal.pone.0160835. eCollection 2016.

10.

Immunohistochemical Expression of B Cell Lymphoma2 with Clinicopathological Correlation in Triple Negative Breast Cancers in Northern Pakistan.

Zubair M, Hashmi SN, Afzal S, Muhammad I, Din HU, Ahmed R.

Asian Pac J Cancer Prev. 2016;17(7):3619-22.

11.

Identification of novel biomarkers associated with poor patient outcomes in invasive breast carcinoma.

Canevari RA, Marchi FA, Domingues MA, de Andrade VP, Caldeira JR, Verjovski-Almeida S, Rogatto SR, Reis EM.

Tumour Biol. 2016 Oct;37(10):13855-13870. Epub 2016 Aug 2.

PMID:
27485113
12.

High Ki67/BCL2 index is associated with worse outcome in early stage breast cancer.

Min KW, Kim DH, Do SI, Pyo JS, Chae SW, Sohn JH, Kim K, Lee HJ, Kim DH, Oh S, Choi SH, Park YL, Park CH, Kwon MJ, Moon KM.

Postgrad Med J. 2016 Dec;92(1094):707-714. doi: 10.1136/postgradmedj-2015-133531. Epub 2016 May 24.

PMID:
27222586
13.

BAG-1/SODD, HSP70, and HSP90 are potential prognostic markers of poor survival in node-negative breast carcinoma.

Davidson B, Valborg Reinertsen K, Trinh D, Reed W, Bøhler PJ.

Hum Pathol. 2016 Aug;54:64-73. doi: 10.1016/j.humpath.2016.02.023. Epub 2016 Mar 30.

PMID:
27038683
14.

Breastfeeding and Immunohistochemical Expression of ki-67, p53 and BCL2 in Infiltrating Lobular Breast Carcinoma.

Gonzalez-Sistal A, Baltasar-Sánchez A, Menéndez P, Arias JI, Ruibal Á.

PLoS One. 2016 Mar 10;11(3):e0151093. doi: 10.1371/journal.pone.0151093. eCollection 2016.

15.

Spiro-oxindole derivative 5-chloro-4',5'-diphenyl-3'-(4-(2-(piperidin-1-yl) ethoxy) benzoyl) spiro[indoline-3,2'-pyrrolidin]-2-one triggers apoptosis in breast cancer cells via restoration of p53 function.

Saxena R, Gupta G, Manohar M, Debnath U, Popli P, Prabhakar YS, Konwar R, Kumar S, Kumar A, Dwivedi A.

Int J Biochem Cell Biol. 2016 Jan;70:105-17. doi: 10.1016/j.biocel.2015.11.003. Epub 2015 Nov 7.

PMID:
26556313
16.

Ki67/SATB1 ratio is an independent prognostic factor of overall survival in patients with early hormone receptor-positive invasive ductal breast carcinoma.

Laurinavicius A, Green AR, Laurinaviciene A, Smailyte G, Ostapenko V, Meskauskas R, Ellis IO.

Oncotarget. 2015 Dec 1;6(38):41134-45. doi: 10.18632/oncotarget.5838.

17.

Expression of alpha B crystallin and BCL2 in patients with infiltrating ductal carcinoma.

Kim MS, Lee HW, Jun SY, Lee EH.

Int J Clin Exp Pathol. 2015 Aug 1;8(8):8842-56. eCollection 2015.

18.

Histological grade (HG) in invasive ductal carcinomas of the breast of less than 1 cm: clinical and biological associations during progression from HG1 to HG3.

Ruibal Á, Aguiar P, Del Rio MC, Arias JI, Menéndez-Rodríguez P, Gude F, Herranz M.

Anticancer Res. 2015 Jan;35(1):569-73.

PMID:
25550604
19.

The Evaluation of WBP2NL-Related Genes Expression in Breast Cancer.

Nourashrafeddin S, Aarabi M, Modarressi MH, Rahmati M, Nouri M.

Pathol Oncol Res. 2015 Apr;21(2):293-300. doi: 10.1007/s12253-014-9820-8. Epub 2014 Nov 25.

PMID:
25417742
20.

Correlation of clinicopathologic parameters and immunohistochemical features of triple-negative invasive lobular carcinoma.

Harbhajanka A, Lamzabi I, Singh RI, Ghai R, Reddy VB, Bitterman P, Gattuso P.

Appl Immunohistochem Mol Morphol. 2014 Jul;22(6):e18-26. doi: 10.1097/PAI.0b013e3182a5a02d.

PMID:
25003839

Supplemental Content

Loading ...
Support Center